Singapore markets close in 1 hour 46 minutes

Vertex Pharmaceuticals Incorporated (VRTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
234.06+7.48 (+3.30%)
At close: 04:00PM EST
233.68 -0.38 (-0.16%)
After hours: 07:42PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 52.90B
Enterprise value 46.82B
Trailing P/E 24.95
Forward P/E 15.77
PEG Ratio (5 yr expected) 0.32
Price/sales (ttm)7.62
Price/book (mrq)5.55
Enterprise value/revenue 6.57
Enterprise value/EBITDA 15.97

Trading information

Stock price history

Beta (5Y monthly) 0.63
52-week change 30.93%
S&P500 52-week change 322.74%
52-week high 3242.99
52-week low 3176.36
50-day moving average 3206.34
200-day moving average 3200.76

Share statistics

Avg vol (3-month) 31.88M
Avg vol (10-day) 31.58M
Shares outstanding 5254.25M
Implied shares outstanding 6N/A
Float 8253.68M
% held by insiders 10.16%
% held by institutions 193.68%
Shares short (30 Dec 2021) 42.91M
Short ratio (30 Dec 2021) 41.37
Short % of float (30 Dec 2021) 41.15%
Short % of shares outstanding (30 Dec 2021) 41.14%
Shares short (prior month 29 Nov 2021) 42.85M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 323 Aug 2000

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sep 2021

Profitability

Profit margin 30.52%
Operating margin (ttm)37.16%

Management effectiveness

Return on assets (ttm)13.85%
Return on equity (ttm)24.64%

Income statement

Revenue (ttm)7.13B
Revenue per share (ttm)27.56
Quarterly revenue growth (yoy)29.00%
Gross profit (ttm)3.64B
EBITDA 2.77B
Net income avi to common (ttm)2.18B
Diluted EPS (ttm)8.34
Quarterly earnings growth (yoy)27.60%

Balance sheet

Total cash (mrq)6.96B
Total cash per share (mrq)27.38
Total debt (mrq)876.8M
Total debt/equity (mrq)9.20
Current ratio (mrq)4.62
Book value per share (mrq)37.20

Cash flow statement

Operating cash flow (ttm)2.14B
Levered free cash flow (ttm)1.26B